Exact Mass: 825.3868055999999

Exact Mass Matches: 825.3868055999999

Found 23 metabolites which its exact mass value is equals to given mass value 825.3868055999999, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

   
   
   
   
   
   

Eribulin mesylate

Eribulin mesylate

C41H63NO14S (825.3969058)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent

   

Deacetoxyvinzolidine

Deacetoxyvinzolidine

C46H56ClN5O7 (825.3868055999999)


D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids

   

N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetradeca-4,8-dien-2-yl]hexanamide

N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetradeca-4,8-dien-2-yl]hexanamide

C38H67NO18 (825.4357921999999)


   

N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]butanamide

N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]butanamide

C38H67NO18 (825.4357921999999)


   

N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyoctadeca-4,8-dien-2-yl]acetamide

N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyoctadeca-4,8-dien-2-yl]acetamide

C38H67NO18 (825.4357921999999)


   

N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptadeca-4,8-dien-2-yl]propanamide

N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyheptadeca-4,8-dien-2-yl]propanamide

C38H67NO18 (825.4357921999999)


   

N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxypentadeca-4,8-dien-2-yl]pentanamide

N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxypentadeca-4,8-dien-2-yl]pentanamide

C38H67NO18 (825.4357921999999)


   

N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytrideca-4,8-dien-2-yl]heptanamide

N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytrideca-4,8-dien-2-yl]heptanamide

C38H67NO18 (825.4357921999999)


   

N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxydodeca-4,8-dien-2-yl]octanamide

N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxydodeca-4,8-dien-2-yl]octanamide

C38H67NO18 (825.4357921999999)


   

GPLGIAGQ (TFA)

GPLGIAGQ (TFA)

C33H54F3N9O12 (825.384384)


GPLGIAGQ TFA, a MMP2-cleavable polypeptide, is used as a stimulus-sensitive linker in both liposomal and micellar nanocarriers for MMP2-triggered tumor targeting. GPLGIAGQ TFA can be used to synthesis unique MMP2-targeted photosensitizer in photodynamic therapy (PDT)[1][2][3].

   

3-({1-[(1-{[({1-[(1-carboxy-2-phenylethyl)-c-hydroxycarbonimidoyl]ethyl}-c-hydroxycarbonimidoyl)methyl]-c-hydroxycarbonimidoyl}-2-hydroxy-3-methylbutyl)-c-hydroxycarbonimidoyl]ethyl}-c-hydroxycarbonimidoyl)-3-({1-hydroxy-2-[(1-hydroxy-2-phenylethylidene)amino]-3-methylbutylidene}amino)propanoic acid

3-({1-[(1-{[({1-[(1-carboxy-2-phenylethyl)-c-hydroxycarbonimidoyl]ethyl}-c-hydroxycarbonimidoyl)methyl]-c-hydroxycarbonimidoyl}-2-hydroxy-3-methylbutyl)-c-hydroxycarbonimidoyl]ethyl}-c-hydroxycarbonimidoyl)-3-({1-hydroxy-2-[(1-hydroxy-2-phenylethylidene)amino]-3-methylbutylidene}amino)propanoic acid

C40H55N7O12 (825.390851)


   

(3r)-3-{[(1s)-1-{[(1r,2s)-1-[({[(1r)-1-{[(1s)-1-carboxy-2-phenylethyl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}methyl)-c-hydroxycarbonimidoyl]-2-hydroxy-3-methylbutyl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}-3-{[(2s)-1-hydroxy-2-[(1-hydroxy-2-phenylethylidene)amino]-3-methylbutylidene]amino}propanoic acid

(3r)-3-{[(1s)-1-{[(1r,2s)-1-[({[(1r)-1-{[(1s)-1-carboxy-2-phenylethyl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}methyl)-c-hydroxycarbonimidoyl]-2-hydroxy-3-methylbutyl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}-3-{[(2s)-1-hydroxy-2-[(1-hydroxy-2-phenylethylidene)amino]-3-methylbutylidene]amino}propanoic acid

C40H55N7O12 (825.390851)


   

4-amino-8-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-3-hydroxy-n-[5,8,11-trihydroxy-6-(c-hydroxycarbonimidoylmethyl)-3,9-bis[3-(n-hydroxyformamido)propyl]-2-oxo-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-12-yl]octanimidic acid

4-amino-8-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-3-hydroxy-n-[5,8,11-trihydroxy-6-(c-hydroxycarbonimidoylmethyl)-3,9-bis[3-(n-hydroxyformamido)propyl]-2-oxo-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-12-yl]octanimidic acid

C34H51N9O15 (825.3504456)


   

(3s,4s)-4-amino-8-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-3-hydroxy-n-[(3s,6r,9s,12r)-5,8,11-trihydroxy-6-(c-hydroxycarbonimidoylmethyl)-3,9-bis[3-(n-hydroxyformamido)propyl]-2-oxo-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-12-yl]octanimidic acid

(3s,4s)-4-amino-8-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-3-hydroxy-n-[(3s,6r,9s,12r)-5,8,11-trihydroxy-6-(c-hydroxycarbonimidoylmethyl)-3,9-bis[3-(n-hydroxyformamido)propyl]-2-oxo-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-12-yl]octanimidic acid

C34H51N9O15 (825.3504456)


   

methyl (1s,2r,4r)-4-{[(2s,4s,5r,6s)-4-(dimethylamino)-5-{[(2s,5s,6r)-5-{[(2s,5s,6r)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-6,11-dioxo-2-(2-oxopropyl)-3,4-dihydro-1h-tetracene-1-carboxylate

methyl (1s,2r,4r)-4-{[(2s,4s,5r,6s)-4-(dimethylamino)-5-{[(2s,5s,6r)-5-{[(2s,5s,6r)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-6,11-dioxo-2-(2-oxopropyl)-3,4-dihydro-1h-tetracene-1-carboxylate

C43H55NO15 (825.3571519999999)


   

[(2r,3s,4s,5r,6s)-6-{[(2s,3r,4r,5r,6s)-2-{4-[(2s,11s)-11-(acetyloxy)-4-hydroxy-9-[(2s)-2-methylbutanoyl]-1,5,9-triazacyclotridec-4-en-2-yl]phenoxy}-4,5-dihydroxy-6-methyloxan-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2s)-2-methylbutanoate

[(2r,3s,4s,5r,6s)-6-{[(2s,3r,4r,5r,6s)-2-{4-[(2s,11s)-11-(acetyloxy)-4-hydroxy-9-[(2s)-2-methylbutanoyl]-1,5,9-triazacyclotridec-4-en-2-yl]phenoxy}-4,5-dihydroxy-6-methyloxan-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2s)-2-methylbutanoate

C40H63N3O15 (825.4258968)


   

methyl (1r,2s,4s)-4-{[(2r,4s,5s,6s)-4-(dimethylamino)-5-{[(2s,5s,6s)-5-{[(2s,5s,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-6,11-dioxo-2-(2-oxopropyl)-3,4-dihydro-1h-tetracene-1-carboxylate

methyl (1r,2s,4s)-4-{[(2r,4s,5s,6s)-4-(dimethylamino)-5-{[(2s,5s,6s)-5-{[(2s,5s,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-2,5,7-trihydroxy-6,11-dioxo-2-(2-oxopropyl)-3,4-dihydro-1h-tetracene-1-carboxylate

C43H55NO15 (825.3571519999999)